Cargando…

Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy

Fatty acid binding protein 4 (FABP4) is a member of the intracellular lipid-binding protein family, responsible for the transportation of fatty acids. It is considered to express mainly in adipose tissues, and be strongly associated with inflammation, obesity, diabetes and cardiovasculardiseases. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ji, Qiao, Congzhen, Chang, Lin, Guo, Yanhong, Fan, Yanbo, Villacorta, Luis, Chen, Y. Eugene, Zhang, Jifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905683/ https://www.ncbi.nlm.nih.gov/pubmed/27294862 http://dx.doi.org/10.1371/journal.pone.0157372

Ejemplares similares

Connective Tissue Growth Factor Overexpression in Cardiomyocytes Promotes Cardiac Hypertrophy and Protection against Pressure Overload
por: Panek, Anna N., et al.
Publicado: (2009)

Correction: Connective Tissue Growth Factor Overexpression in Cardiomyocytes Promotes Cardiac Hypertrophy and Protection against Pressure Overload
por: Panek, Anna N., et al.
Publicado: (2009)

Neonatal Heart Responds to Pressure Overload With Differential Alterations in Various Cardiomyocyte Maturation Programs That Accommodate Simultaneous Hypertrophy and Hyperplasia
por: Ding, Xiaoning, et al.
Publicado: (2020)

T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure
por: Gröschel, Carina, et al.
Publicado: (2017)

The valosin‐containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload
por: Zhou, Ning, et al.
Publicado: (2017)

Abnormalities in lysine degradation are involved in early cardiomyocyte hypertrophy development in pressure-overloaded rats
por: Liu, Jialing, et al.
Publicado: (2021)

Laminar Flow Attenuates Macrophage Migration Inhibitory Factor Expression in Endothelial Cells
por: Qiao, Congzhen, et al.
Publicado: (2018)

Ndufs1 Deficiency Aggravates the Mitochondrial Membrane Potential Dysfunction in Pressure Overload-Induced Myocardial Hypertrophy
por: Zou, Rongjun, et al.
Publicado: (2021)

Cytosolic CARP Promotes Angiotensin II- or Pressure Overload-Induced Cardiomyocyte Hypertrophy through Calcineurin Accumulation
por: Chen, Ci, et al.
Publicado: (2014)

Pressure overload promotes cystatin C secretion of cardiomyocytes to regulate the MAPK signaling pathway and mediate cardiac hypertrophy
por: Shen, Yi, et al.
Publicado: (2020)

Effects of a Proteasome Inhibitor on Cardiomyocytes in a Pressure-Overload Hypertrophy Rat Model: An Animal Study
por: Kim, In-Sub, et al.
Publicado: (2017)

NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin
por: Yue, Rongchuan, et al.
Publicado: (2021)

OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling
por: Feng, Yizhou, et al.
Publicado: (2023)

Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy
por: Sato, Hiroshi, et al.
Publicado: (1997)

The role of androgens in pressure overload myocardial hypertrophy
por: Schafstedde, Marie, et al.
Publicado: (2023)

Cellular hypertrophy occurs before interstitial fibrosis in pressure-overload heart failure
por: Shah, Ravi, et al.
Publicado: (2013)

Pressure overload by suprarenal aortic constriction in mice leads to left ventricular hypertrophy without c-Kit expression in cardiomyocytes
por: Nicks, Amy M., et al.
Publicado: (2020)

Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Schiattarella, Gabriele G., et al.
Publicado: (2018)

Lack of Contribution of p66shc to Pressure Overload-Induced Right Heart Hypertrophy
por: Hirschhäuser, Christine, et al.
Publicado: (2020)

Interstitial expansion in pressure overload left ventricular hypertrophy
por: Treibel, Thomas A, et al.
Publicado: (2013)

Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload
por: Zhang, Nan, et al.
Publicado: (2021)

Cytokine mRNA Degradation in Cardiomyocytes Restrains Sterile Inflammation in Pressure-Overloaded Hearts
por: Omiya, Shigemiki, et al.
Publicado: (2020)

Cardiomyocyte ZKSCAN3 regulates remodeling following pressure‐overload
por: Ouyang, Xiaosen, et al.
Publicado: (2023)

Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure
por: Sun, Simei, et al.
Publicado: (2019)

miR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts
por: Chang, Wei-Ting, et al.
Publicado: (2022)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

Extracellular high‐mobility group box 1 mediates pressure overload‐induced cardiac hypertrophy and heart failure
por: Zhang, Lei, et al.
Publicado: (2015)

Mechanisms of Chinese Medicine Xinmailong’s protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes
por: Qi, Jianyong, et al.
Publicado: (2017)

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Dai, Jia, et al.
Publicado: (2013)

Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch
por: Cheng, Wen‐Pin, et al.
Publicado: (2018)

FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In Vivo
por: Kuhn, Christian, et al.
Publicado: (2021)

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
por: Xiao, Jinfeng, et al.
Publicado: (2012)

Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Muthuramu, Ilayaraja, et al.
Publicado: (2022)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
por: Zhen, Changlin, et al.
Publicado: (2023)

The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy
por: Yang, Lei, et al.
Publicado: (2016)

Yap1 modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload
por: Yue, Peng, et al.
Publicado: (2022)

Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy
por: Yang, Chongzhe, et al.
Publicado: (2022)

Postnatal Ablation of Foxm1 from Cardiomyocytes Causes Late Onset Cardiac Hypertrophy and Fibrosis without Exacerbating Pressure Overload-Induced Cardiac Remodeling
por: Bolte, Craig, et al.
Publicado: (2012)

Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload
por: Slavic, Svetlana, et al.
Publicado: (2017)

Knockout of the ATPase inhibitory factor 1 protects the heart from pressure overload-induced cardiac hypertrophy
por: Yang, Kevin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4idgmb8l65d192m04gi33kich1